skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello Peter and Ryan,
i. Apologies, but i need a clarification. Are Shopify's existing shares Class A? I was thinking of existing shares which have done well, but was wondering if I should wait before I add and what would be a good price to add?
ii. How long should one wait before pulling the plug on GUD? I only invested due to management, but the time frame seems a bit much for any upside here?
iii. Do you still like Covolan and is it good time to add?
iv. Please suggest which is better option: HMMJ , MJJ (the actively managed ETF) or CGOC (not in your list but if you know much about it please, Cannibis growth opportunity )
Thanks again and appreciate your input.
Read Answer Asked by umedali on February 22, 2018
Q: I am considering selling my 4-5% position in gud and buying a 2-@1/2% position in each of cov and rht. I am not concerned with the fact that these 2 are small caps and gud is "much larger". I also have full positions in sis. exe and most recently pfe on the recent sell off. do you consider this to be a worthwhile move? I believe gud has had more than enough time, and opportunity imho ( there have been a few large distressed drug companies with assets for sale while gud has been twiddling their thumbs counting their cash) plus I do not want to be in the unenviable position of holding gud if or when you decide to replace it in your portfolios. I do have a lot of patience but the way I see gud they seem to waiting for a ridiculously cheap opportunity that may never happen.

on a side note, when searching for a 2 letter security on your search window many times I've had to scroll waaaaaaaaaaay down the list to find the company, there are 3 letter symbols no where close to the 2 letters put into search that come up before the desired company is listed, is this some kind of glitch that can be fixed?

thanks in advance
ps also thanks for creating the opportunity (obviously not on purpose) to buy syz at a discount on friday, lol.

Read Answer Asked by Tom on February 21, 2018
Q: Hi Group appreciate your input on the following . Why are we holding CXI + GUD both have been off (trading well off their highs) for a considerable amount of time . Why are you still recommending holding these poorly performing stocks why not sell them and get into something that is trading upwards??. What do you recommend and why Thank you
Read Answer Asked by Terence on February 17, 2018
Q: ATE is set to release final Phase 2b results of their lead drug ATB-346, in 4weeks. I'm curious if you have any relevant information on the outlook of this drug and the company overall? I understand GUD has funds deployed here. And my main question is if the trial results show less GI tract bleeding (the issue with prolonged doses of Naproxen) and better efficacy results than Aleve then how could the drug or company's valuation be estimated? Sales numbers for Bayer's Aleve that could be extrapolated? thanks
Read Answer Asked by Gordon on February 16, 2018
Q: Uber-guru Warren Buffett once said something along the lines of "Better to buy a great company at a fair price than to buy an average company at a great price". After the market pull-back of the last few days, there may be some great companies available at fair or even better prices. Can you name a few?
Read Answer Asked by Bryan on February 08, 2018
Q: What would be your favourite healthcare stocks in Canada and Us?
Thank you
Read Answer Asked by Josette on February 06, 2018
Q: I have a reasonable balance of these stocks in my TFSA. With the pullback, should I add to a laggard or introduce a new one? Open to ETF as well. Long term.
Have great weekend.
Paul
Read Answer Asked by Paul on February 05, 2018
Q: Cheers. First of all thanks for recent Avo encouragement. Worked out very well.

What are the consequences to Gud if companies like Amazon get into the pharmaceutical business in a big way? Also there is lots of talk by governments and insurance companies of signing contracts with drug providers where drug costs are lowered by 35-40%. Quebec signed such a contract awhile ago and recent reports suggest the other provinces are also in the process of doing so. I believe this is the area where Jonathan Goodman and his team have their expertise and previous success. I have a 3 year invested interest in Gud and wondering how these events are affecting Guds future potential and even its present share price decline?
Would like to hear your valued thots on this.
Thanks
Terry
Read Answer Asked by Terry on February 02, 2018
Q: Hi Peter, Ryan, and Team,

I manage a TFSA for my daughter-in-law. She holds 165 shares of GUD and is presently down $419. I know that you're still positive on GUD, but she's beginning to lose patience. Would you be OK with selling GUD to buy COV (realizing its size makes it more risky) or perhaps buying XHC (which we can do commission free) to stay in the same sector in an otherwise balanced portfolio?
She's 49 years old and is using her TFSA as forced savings by adding $100 each month. (I invest the $100 in a commission-free ETF by looking at the 'best ones' and invest in the one that's down the most on the day that the $100 appears in her account.)

Thanks in advance for your insight.

Read Answer Asked by Jerry on February 02, 2018
Q: Hi, wondering what you would suggest as best buys this week for short term gains given the decline in many sectors or stocks showing new momentum trends? And any long term holds being offered at a good discount to pick up? Thanks for all your good advice!
Read Answer Asked by Kim on January 29, 2018